Prevention and treatment of stroke: where do we stand?
Gibaldi
M
M
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle 98195, USA.
D001241:Aspirin / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use
D014859:Warfarin; D001241:Aspirin